GSK-931145-[11C]

N/A

Report date: 2025/11/24 11:49:52
NME

Base Information

Drug NameGSK-931145-[11C]
Drug Alias NameGSK-931145-[11C][11C]GSK-931145
ClassificationSmall moleculesRadiation-emitting products > Nuclides > Carbon > 11CRadiation-emitting products > Radionuclide Drug Conjugates +[5] 
Mechanisms of ActionGlycine transporter 1 inhibitors
TargetsGlycine transporter 1
Therapy Area/IndicationsDiagnostic agents
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsDiagnostic agents

Other Information

ATC CodeN/A
Related LinksN/A